Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Todd Van Tol

Head of Health & Life Sciences, North America, Oliver Wyman

GOP leadership may need to make some concessions to gain support for their bill. Unlikely to change? The focus on younger enrollees.

Head of Health & Life Sciences, North America, Oliver Wyman
Principal, Oliver Wyman

Inside the GOP proposal to shore up the individual insurance market.

Practice Leader, Oliver Wyman Actuarial Consulting
Head of Health & Life Sciences, North America, Oliver Wyman

Oliver Wyman research reveals that majority of health insurers surveyed remain committed to the ACA exchanges, but with some tweaks and continued watchfulness.

Partner, Oliver Wyman Actuarial Consulting
Head of Health & Life Sciences, North America, Oliver Wyman

While health reform may temporarily be stalled, there are many strategic implications for key players in the industry.

Head of Health & Life Sciences, North America, Oliver Wyman

Think you’re ready for transformation? First, take this change-readiness assessment.

Head of Health & Life Sciences, North America, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

...

Head of Health & Life Sciences, North America, Oliver Wyman
Principal, Oliver Wyman

Even amidst the uncertainty of repeal and replace, we see some meaningful trends taking shape. Read our predictions for 2017.

Managing Partner, Health & Life Sciences, Oliver Wyman
Head of Health & Life Sciences, North America, Oliver Wyman

Trendspotting in unpredictable times. This infographic highlights five predictions for 2017.

Managing Partner, Health & Life Sciences, Oliver Wyman
Head of Health & Life Sciences, North America, Oliver Wyman

For new healthcare CEOs who come from outside the industry, there is not just one learning curve, but many.

Head of Health & Life Sciences, North America, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Oliver Wyman's Todd Van Tol and Sukanya Soderland spoke at this year's AHIP Institute and have these observations to share about the outlook for payers.

Head of Health & Life Sciences, North America, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts

Insights in your inbox

Subscribe